ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

フルドロコルチゾン酢酸エステル

Fludrocortisone Acetate

HCID 225609
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
514-36-3
標準SMILES
CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C
InChIKey
SYWHXTATXSMDSB-GSLJADNHSA-N
分子式
C23H31FO6
平均分子量
422.5 g/mol
単同位体質量
422.21046687

概要

Fludrocortisone acetate is an acetate ester resulting from the formal condensation of the primary hydroxy group of fludrocortisone with acetic acid. A synthetic corticosteroid, it has glucocorticoid actions about 10 times as potent as hydrocortisone, while its mineralocorticoid actions are over 100 times as potent. It is used in partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenal hyperplasia. It is a tertiary alpha-hydroxy ketone, a mineralocorticoid, a 17alpha-hydroxy steroid, an 11beta-hydroxy steroid, a 20-oxo steroid, an acetate ester, a 3-oxo-Delta(4) steroid and a fluorinated steroid. It is functionally related to a fludrocortisone.

名称と識別子

優先名称
Fludrocortisone Acetate
IUPAC
[2-[(8S,9R,10S,11S,13S,14S,17R)-9-fluoro-11,17-dihydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate
現地名
フルドロコルチゾン酢酸エステル
英語名
Fludrocortisone acetate
分子式
C23H31FO6
分子量
422.49

名称と別名

FLUDROCORTISONE ACETATE514-36-3ScherofluronAlflorone acetateFlorinef acetateFludrocortisone 21-acetateCortef-FFluorocortisol acetateFluorocortisone acetateFluohydrocortisone acetate9alpha-Fluorohydrocortisone acetate9alpha-Fluorohydrocortisone 21-acetate
名称をさらに表示
21-(アセチルオキシ)-9-フルオロ-11β,17-ジヒドロキシプレグナ-4-エン-3,20-ジオン9-フルオロコルチソール21-アセタートフルドロコルチゾン酢酸エステル酢酸フルドロコルチゾン9α-フルオロヒドロコルチゾンアセタート9α-フルオロ-11β,17α,21-トリヒドロキシプレグナ-4-エン-3,20-ジオン21-アセタート21-アセトキシ-9α-フルオロ-11β,17α-ジヒドロキシプレグナ-4-エン-3,20-ジオンフルドロコルチゾンアセタートアルフロロンアセタートスケロフルロンフロリンfフルドロコルチゾン酢酸エステル (JP17)2-[(1R,3aS,3bS,9aS,9bR,10S,11aS)-9b-フルオロ-1,10-ジヒドロキシ-9a,11a-ジメチル-7-オキソ-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-シクロペンタ[a]フェナントレン-1-イル]-2-オキソエチル アセタート9-FLUOROHYDROCORTISONE ACETATE9αNSC 15186cortineffalfloroneacetate9-FLUOROCORTISOL ACETATE
V47IF0PVH4U 4845NSC-15186Fludrocortisoni acetasDTXSID20230629-Fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione 21-acetateCHEBI:5102NSC15186

データベース識別子

CAS
514-36-3
PubChem CID
225609
DTXSID
DTXSID2023062
ChEMBL
CHEMBL1201010
ChEBI
CHEBI:5102
UNII
V47IF0PVH4
EC Number
208-180-4
Nikkaji
J6.287A

物性

構造計算による物性

XLogP
1.7
極性表面積
101 Ų
水素結合供与体数
2
水素結合受容体数
7
回転可能結合数
4
重原子数
30
形式電荷
0
複雑度
838

実験および物理化学的性質

DrugsPharmaceuticals -> Dermatologicals -> Corticosteroids, dermatological preparations
LipidsLipids -> Sterol Lipids [ST] -> Steroids [ST02] -> C21 steroids (gluco/mineralocorticoids, progestogins) and derivatives [ST0203]
Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section189.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
233 · 233-234°C
沸点
575.1 · 575.1±50.0 °C(Predicted)
比旋光度
23 · D23 +123° (c = 0.64 in chloroform)
比重(密度)
1.0953 · 1.0953 (rough estimate)
屈折率
1.598 · 1.5980 (estimate)
貯蔵温度
2 · 2-8°C
溶解性
水にほとんど溶けず、無水エタノールにやや溶けにくい。
酸解離定数(Pka)
12.06 · 12.06±0.70(Predicted)
外見
Solid
色
ホワイトからオフホワイト
由来生物
synthetic
水溶解度
54 mg/L · 54mg/L(25℃)
InChIKey
UUHYILPJUKGJDI-XYNXPQAZSA-N
SMILES
F[C@]12[C@H](C[C@@]3([C@@](O)(C(=O)COC(=O)C)CC[C@@]3([H])[C@]1([H])CCC1=CC(=O)CC[C@]21C)C)O |&1:1,2,4,5,16,18,28,r|
CAS データベース
514 · 514-36-3(CAS DataBase Reference)
EPAの化学物質情報
Fluorocortisone acetate (514-36-3)

化学的性質

化学的特性Crystalline Solid

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (95.2%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P280, P301+P317, P318, P330, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 42 reports by companies from 5 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Other Safety InformationIMAP assessments - Pregn-4-ene-3,20-dione, 21-(acetyloxy)-9-fluoro-11,17-dihydroxy-, (11.beta.)-: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (95.2%)

毒性情報

Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Fludrocortisone acetate

vNo-DILI-concern

0

No match

DOI:10.1016/j.drudis.2016.02.015

EPA Human Health Benchmarks for Pharmaceuticals · 6 件

Fludrocortisone acetate

0.001

0.004

The usual dose is 0.1 mg of fludrocortisone acetate tablets daily, although dosage ranging from 0.1 mg three times a week to 0.2 mg daily has been employed. In the event transient hypertension develops as a consequence of therapy, the dose should be reduced to 0.05 mg daily.

Data used to generate the benchmarks include the following: Lowest Daily Dose (LDD): 0.043 mg/day, Lowest Therapeutic Dose (LTD): 0.0005 mg/kg-day, and Screening Dose: 0.0000002 mg/kg-day.

18-May-21

安全データ

wgk
3
rtecs
TU5050000
毒性
LD50 oral in rat: > 1gm/kg
hs_code
2937220000
risk_code
63
hazard_code
Xn
safety_code
22-26-36
Hazard Classifications
Acute Tox. 4 OralRepr. 2
ストレージクラス
11 - Combustible Solids

化学と産業

応用分野 · 2 件

説明Fludrocortisone acetate is the acetate form of the synthetic corticosteroid fludrocortisone, which is a mineralocorticoid receptor agonist. Fludrocortisone acetate (0.1-5 μg/animal) promotes sodium retention in rats in a dose-dependent manner with 37% of sodium excreted compared with control when used at a dose of 5 μg/animal. Formulations containing fludrocortisone acetate have been used in the treatment of Addison’s disease.

一般的な説明Fludrocortisone acetate,21-acetyloxy-9-fluoro-11β,17-dihydroxypregn-4-ene-3,20-dione, 9α-fluorohydrocortisone (Florinef Acetate), isused only for the treatment of Addison disease and for inhibitionof endogenous adrenocortical secretions. It has up to about 800 times the MC activity of hydrocortisone and about 11 times the GC activity. Its potent activity stimulated the synthesis and study of the many fluorinated steroids. Although its great salt-retaining activity limits its use to Addison disease, it has sufficient GC activity that in some cases of the disease, additional GCs need not be prescribed.

上流・下流製品情報

上流原料

Phosphorus oxychloridehydrogen fluoride次亜臭素酸塩酢酸 ヒドロコルチゾンフッ化水素酸9,11-Epoxypregn-4-ene-17,21-diol-3,20-dione 21-acetateジクロロメタンピリジニウムポリ(ヒドロゲンフルオリド)

下流製品

イソフルプレドンアセタート
補足説明 · 1 件

定義ChEBI: An acetate ester resulting from the formal condensation of the primary hydroxy group of fludrocortisone with acetic acid. A synthetic corticosteroid, it has glucocorticoid actions about 10 times as potent as hydrocortisone, while its mineralocorticoid acti ns are over 100 times as potent. It is used in partial replacement therapy for primary and secondary adrenocortical insufficiency in Addison's disease and for the treatment of salt-losing adrenal hyperplasia.

関連反応

1 件
反応記録を作成
HRID 2197394 の反応式
HRID 2197394反応物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート